Skip to Main Content

Author Details

David N Louis
1986
374
117
PMIDPaper TitleJournal TitlePublished Year
36700349Atretic cephalocele and encephalocele: A single-institution clinicopathological study.J Cutan Pathol2023
37409518A vade mecum for crossing the second translational "valley of death" in brain tumor classification.2023
35710121The 2021 World Health Organization Classification of Tumors of the Central Nervous System: What Neuroradiologists Need to Know.2022
34596684Response to letter to the editor by Moudgil-Joshi and Kaliaperumal.Neuro-Oncology2021
33592174Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis.Cell2021
33470459Atretic cephalocele: Report of an infrequent dermatopathologic finding.J Cutan Pathol2021
34185076The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.Neuro Oncol2021
31219344Data Sets for the Reporting of Tumors of the Central Nervous System: Recommendations From The International Collaboration on Cancer Reporting.Arch Pathol Lab Med2020
32313491Roses and rosettes-the two sides of James Homer Wright.Baylor University Medical Center Proceedings2020
32307792cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading.Brain Pathol2020
31996992cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas.Acta Neuropathol2020
32856766Clinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospital.FASEB J2020
32502305cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumors.Brain Pathol2020
31302204A half century of change in diagnostic neuropathology: from the giants of yore to current brain tumor classification.Human Pathology2020
30848347cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF<sup>V600E</sup> mutation.Acta Neuropathol2019
30496526Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma.Neuro Oncol2019
30584643The impact of histopathology and NAB2-STAT6 fusion subtype in classification and grading of meningeal solitary fibrous tumor/hemangiopericytoma.Acta Neuropathol2019
31038238cIMPACT-NOW: a practical summary of diagnostic points from Round 1 updates.Brain Pathol2019
31036078PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma.Acta Neuropathol Commun2019
30852247Characterization of applicants for residency training in pathology: Does diversity exist?Annals of Diagnostic Pathology2019
29497819cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant.Acta Neuropathol2018
30259105cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".Acta Neuropathol2018
30066398Localized crystal-storing histiocytosis of the posterior fossa.Neuropathology2018
30533276Implementing the DICOM Standard for Digital Pathology.J Pathol Inform2018
29674595Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq.Science2018
29666968A feast of reviews about brain and pituitary tumor pathology.Brain Tumor Pathology2018
29476136A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle.Nat Commun2018
29372318cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC).Acta Neuropathol2018
29687258Novel, improved grading system(s) for IDH-mutant astrocytic gliomas.Acta Neuropathol2018
29548048Grading of Diffuse Astrocytic Gliomas: A Review of Studies Before and After the Advent of IDH Testing.Seminars in Neurology2018
27909809Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy.Acta Neuropathol2017
29016871Cost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendations.Neuro Oncol2017
28901970The 2016 WHO classification of central nervous system tumors: what neurologists need to know.Current Opinion in Neurology2017
28801693Grading of diffuse astrocytic gliomas: Broders, Kernohan, Zülch, the WHO⿦ and Shakespeare.Acta Neuropathologica2017
28360267Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq.Science2017
28472509Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma.Neuro Oncol2017
28395084The Utility of Expert Diagnosis in Surgical Neuropathology: Analysis of Consultations Reviewed at 5 National Comprehensive Cancer Network Institutions.Journal of Neuropathology and Experimental Neurology2017
29296164Correction.Journal of Radiology Case Reports2017
27997995cIMPACT-NOW (the consortium to inform molecular and practical approaches to CNS tumor taxonomy): a new initiative in advancing nervous system tumor classification.Brain Pathol2017
27688263Integrating molecular markers into the World Health Organization classification of CNS tumors: a survey of the neuro-oncology community.Neuro Oncol2017
28170043Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas.Neuro Oncol2017
27974037Case 38-2016. A 52-Year-Old Woman with Recurrent Oligodendroglioma.New England Journal of Medicine2016
27418206Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004-2012, varying).J Neurooncol2016
27279154Impact of histopathological transformation and overall survival in patients with progressive anaplastic glioma.J Clin Neurosci2016
27312063The flowering of pathology as a medical discipline in Boston, 1892-c.1950: W.T. Councilman, FB Mallory, JH Wright, SB Wolbach and their descendants.Modern Pathology2016
27471182Health Care Infrastructure for Financially Sustainable Clinical Genomics.J Mol Diagn2016
27200167Angioleiomyoma of the falx.Journal of Radiology Case Reports2016
27157931The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.Acta Neuropathol2016
26098131Computational Pathology: A Path Ahead.Arch Pathol Lab Med2016
26487540BRAF alteration status and the histone H3F3A gene K27M mutation segregate spinal cord astrocytoma histology.Acta Neuropathol2016
  • 1 - 50 of 373

Recommended Authors

Collaborators

Co-authored papers 57
Brigham and Women's Hospital
Co-authored papers 35
New York University.
Co-authored papers 33
Massachusetts General Hospital
Co-authored papers 24
Massachusetts General Hospital
Co-authored papers 23
Co-authored papers 20
Co-authored papers 20
National Cancer Institute
Co-authored papers 19
University of California san francisco
Co-authored papers 18
Heinrich Heine University
Co-authored papers 18
Co-authored papers 13
Massachusetts General Hospital, Harvard Medical School
Co-authored papers 13
Co-authored papers 11
St. Jude Children's Research Hospital
Co-authored papers 11
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 11
Co-authored papers 11
Co-authored papers 11
The Hospital for Sick Children
Co-authored papers 10
University Hospital and University of Zurich
Co-authored papers 9
Broad Institute of MIT and Harvard
Co-authored papers 9
Co-authored papers 9
Charite University Medicine Berlin
Co-authored papers 9
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 9
Co-authored papers 9
Co-authored papers 9
Harvard Medical School
Co-authored papers 9
Co-authored papers 8
Mayo Clinic
Co-authored papers 8
Broad Institute of MIT and Harvard
Co-authored papers 8
Wellcome Trust-Medical Research Council Stem Cell Institute and.
Co-authored papers 7